Financial statements Biocontrol Polska
Balance sheet data of BIOCONTROL POLSKA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 3 956 702,99 | 4 264 832,69 | 3 403 404,15 | 3 834 079,09 | 4 136 226,81 | 3 953 923,94 |
| A. Fixed assets | 116 935,51 | 55 701,55 | 284 884,84 | 399 978,22 | 320 701,22 | 220 761,38 |
| B. Current assets | 3 839 767,48 | 4 209 131,14 | 3 118 519,31 | 3 434 100,87 | 3 815 525,59 | 3 733 162,56 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | 0,00 |
| D. Own shares (stocks) | - | - | - | - | - | 0,00 |
| Total liabilities | 3 956 702,99 | 4 264 832,69 | 3 403 404,15 | 3 834 079,09 | 4 136 226,81 | 3 953 923,94 |
| A. Equity | 3 643 082,12 | 4 011 459,91 | 3 198 549,16 | 3 393 092,69 | 3 802 138,38 | 3 743 404,74 |
| B. Liabilities and provisions for liabilities | 313 620,87 | 253 372,78 | 204 854,99 | 440 986,40 | 334 088,43 | 210 519,20 |
| I. Long-term liabilities | - | - | - | - | - | 0,00 |
| II. Short-term liabilities | 299 172,73 | 248 328,94 | 174 254,99 | 418 036,40 | 300 851,63 | 189 416,60 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.